FRAT-2 Preferentially Increases Glycogen Synthase Kinase 3β-mediated Phosphorylation of Primed Sites, Which Results in Enhanced Tau Phosphorylation

This publication has 41 references indexed in Scilit:

• Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event
  Biochemical Journal, 2004
• Glycogen Synthase Kinase-3β Mutagenesis Identifies a Common Binding Domain for GBP and Axin
  Published by Elsevier ,2002
• GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activity
  FEBS Letters, 2001
• Molecular Cloning and Characterization of FRAT2, Encoding a Positive Regulator of the WNT Signaling Pathway
  Biochemical and Biophysical Research Communications, 2001
• A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐catenin
  FEBS Letters, 1999
• Phosphorylation of tau protein by recombinant GSK‐3β: pronounced phosphorylation at select Ser/Thr‐Pro motifs but no phosphorylation at Ser262 in the repeat domain
  FEBS Letters, 1999
• The τ Protein in Human Cerebrospinal Fluid in Alzheimer's Disease Consists of Proteolytically Derived Fragments
  Journal of Neurochemistry, 1997
• Microtubule‐associated Protein Tau, Paired Helical Filaments, and Phosphorylation^a
  Annals of the New York Academy of Sciences, 1993
• Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments
  FEBS Letters, 1993
• Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase
  Neuroscience Letters, 1992